Imunon Announces $7 Million Registered Direct Offering
at www.tipranks.com (Wed, 31-Dec 8:29 AM)
IMUNON Advances Phase 3 OVATION 3 Ovarian Cancer Study: Promising Results Show Median 13-Month Survival Benefit
Market Chameleon (Tue, 14-Oct 8:49 AM)
